Stark Law

DEADLINE ALERT for FLGT, YSG, BCS, and OLO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, November 7, 2022
GLOBE, Anti-Kickback Statute, Genetics, SEC, Company, Suite, Law, Remuneration, Investment, Stark Law, Defendant, IPO, Battle of Saint-Fulgent, Time, Security (finance), Mail, Holding company, Risk management, Barclays

LOS ANGELES, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • The Law Offices of Frank R. Cruz, Los Angeles

FLGT 2-WEEK DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Fulgent Genetics (FLGT) Investors with Significant Losses to Contact the Firm’s Attorneys, Securities Class Action Pending

Retrieved on: 
Monday, November 7, 2022
Disclosure, SAN, Fraud, Steve Berman (lawyer), GLOBE, DOJ, Stark Law, NASDAQ, News, SEC, Genetics, Program, Person, Pharmaceutical industry, Tobacco, Battle of Saint-Fulgent

SAN FRANCISCO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now .
  • A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations.
  • Fulgent Genetics, Inc. (NASDAQ: FLGT) Securities Fraud Class Action:
    The litigation focuses on Fulgents previously claimed very strong and truly outstanding financial results.
  • If you invested in Fulgent and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)

Retrieved on: 
Monday, November 7, 2022
Justice, Company, Securities Exchange Act of 1934, Investment, Time, Anti-Kickback Statute, GLOBE, Exchange, Privacy Office of the U.S. Department of Homeland Security, Suite, U.S. Department of Justice Office of Legislative Affairs, Stark Law, Defendant, NASDAQ, Remuneration, Court, News, GPM, SEC, Stark, Genetics, Pharmaceutical industry, Battle of Saint-Fulgent

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • If you purchased or otherwise acquired Fulgent securities during the Class Period, you may move the Court no later than November 21, 2022 to request appointment as lead plaintiff in this putative class action lawsuit.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fulgent, Yatsen, Barclays, and Warner Bros. and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, November 7, 2022
Warner, Turnaround ADR, Section 11 of the Canadian Charter of Rights and Freedoms, Battle of Saint-Fulgent, HBO Max, Anti-Kickback Statute, ADR, Annual report, U.S. Securities and Exchange Commission, AT, U.S. Department of Defense Strategy for Operating in Cyberspace, SEC, Health, Genetic testing, Disclosure, Company, Prospectus, Medicare, AT&T, GLOBE, Mergers and acquisitions, NYSE, Reward, IPO, Securities Act of 1933, Mission statement, U.S. Department of Justice Office of Legislative Affairs, Stark Law, Remuneration, Patient, Genetics, Complaint, YSG, Sale, HBO, COVID-19, Physician, Defendant, ADS, Justice, Investment, Federal, BCS, NASDAQ, Warner Bros., News, Register, Pharmaceutical industry, Music, Audit, Security (finance), WarnerMedia, Discovery, Barclays, P.C

Fulgent, together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally.

Key Points: 
  • Fulgent, together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally.
  • The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and compliance policies.
  • For more information on the Warner Bros. class action go to: https://bespc.com/cases/WBD
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

ROSEN, A TOP RANKED FIRM, Encourages Fulgent Genetics, Inc. Investors With Losses to Secure Counsel Before Important November 21 Deadline in Securities Class Action – FLGT

Retrieved on: 
Sunday, November 6, 2022
Titan, Health, I-Space (Chinese company), Medicare, Battle of Saint-Fulgent, Reward, Advertising, Anti-Kickback Statute, Federal, Stark Law, NASDAQ, Remuneration, Court, Class, Genetics, Insurance, Tobacco, Pharmaceutical industry

WHAT TO DO NEXT: To join the Fulgent Genetics class action, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Fulgent Genetics class action, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq.
  • If you wish to serve as lead plaintiff, you must move the Court no later than November 21, 2022.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Kessler Topaz Meltzer & Check, LLP Reminds Investors of November 21, 2022 Deadline in Securities Fraud Class Action against Fulgent Genetics, Inc. Investors and Urges Investors with Substantial Losses to Contact the Firm

Retrieved on: 
Saturday, November 5, 2022
Health, Genetic testing, Disclosure, Anti-Kickback Statute, Justice, Medicare, Central District, Lead, Fraud, GLOBE, Battle of Saint-Fulgent, Reward, COVID-19, LLP, Physician, Office of Inspector General, U.S. Department of Health and Human Services, U.S. Department of Justice Office of Legislative Affairs, Stark Law, NASDAQ, District court, Remuneration, COPY, Insurance, News, SEC, Patient, Genetics, Stark, Private investigator, Pharmaceutical industry, Architecture

The action charges Fulgent with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the companys business, operations, and prospects.

Key Points: 
  • The action charges Fulgent with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the companys business, operations, and prospects.
  • As a result of Fulgents materially misleading statements and omissions to the public, Fulgent investors have suffered significant losses.
  • Kessler Topaz Meltzer & Check, LLP encourages Fulgent investors who have suffered significant losses to contact the firm directly to acquire more information.
  • ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP
    Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world.

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That Securities Class Action Lawsuits Have Been Filed on Behalf of Investors in Argo Group International Holdings, Ltd. (ARGO), Fulgent Genetics, Inc. (FLGT), Olo Inc. (OLO), and Encourages Investors t

Retrieved on: 
Friday, November 4, 2022
OLO, Anti-Kickback Statute, GLOBE, Battle of Saint-Fulgent, Kirby, Argo Group, Defendant, Stark Law, Remuneration, Court, Genetics, Argo, Online shopping, Private investigator

Additional information about each case can be found at the links provided below.

Key Points: 
  • Additional information about each case can be found at the links provided below.
  • Kirby McInerney is a New York-based plaintiffs law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.
  • The firms efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

FULGENT GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Fulgent Genetics, Inc. - FLGT

Retrieved on: 
Wednesday, November 2, 2022
Accusative case, Security (finance), Central District, KSF, Genetics, District court, U.S. Securities and Exchange Commission, News, SEC, Battle of Saint-Fulgent, GLOBE, LLC, Stark Law, Anti-Kickback Statute, Court, Justice, Civil investigative demand, Office of Inspector General, U.S. Department of Health and Human Services, U.S. Department of Justice Office of Legislative Affairs, Company, Remuneration, Private investigator

This action is pending in the United States District Court for the Central District of California.

Key Points: 
  • This action is pending in the United States District Court for the Central District of California.
  • If you wish to serve as a lead plaintiff in this class action, you must petition the Court by November 21, 2022.
  • Fulgent and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
  • About Kahn Swick & Foti, LLC
    KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nations premier boutique securities litigation law firms.

DEADLINE ALERT for FLGT, YSG, BCS, and OLO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Wednesday, November 2, 2022
Genetics, IPO, Law, SEC, Battle of Saint-Fulgent, GLOBE, Time, Anti-Kickback Statute, Suite, Investment, Company, Remuneration, Stark Law, Defendant, Security (finance), Mail, Holding company, Risk management, Barclays

LOS ANGELES, Nov. 02, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Nov. 02, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • The Law Offices of Frank R. Cruz, Los Angeles

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – FLGT

Retrieved on: 
Tuesday, November 1, 2022
Titan, Health, Federal, Genetics, Battle of Saint-Fulgent, GLOBE, Advertising, Anti-Kickback Statute, Court, NASDAQ, Reward, Medicare, Remuneration, Class, I-Space (Chinese company), Stark Law, Insurance, Tobacco, Pharmaceutical industry

WHAT TO DO NEXT: To join the Fulgent Genetics class action, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Fulgent Genetics class action, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.